This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources.Find sources: "EEE" psychedelic – news · newspapers · books · scholar · JSTOR (June 2019)
EEE
Names
Preferred IUPAC name
1-(2,4,5-Triethoxyphenyl)propan-2-amine
Other names
2,4,5-Triethoxyamphetamine
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C15H25NO3/c1-5-17-13-10-15(19-7-3)14(18-6-2)9-12(13)8-11(4)16/h9-11H,5-8,16H2,1-4H3 checkY
    Key: PVOHHXSVHWUAMS-UHFFFAOYSA-N checkY
  • InChI=1/C15H25NO3/c1-5-17-13-10-15(19-7-3)14(18-6-2)9-12(13)8-11(4)16/h9-11H,5-8,16H2,1-4H3
    Key: PVOHHXSVHWUAMS-UHFFFAOYAO
  • CCOc1cc(OCC)c(cc1OCC)CC(C)N
Properties
C15H25NO3
Molar mass 267.369 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

EEE (2,4,5-triethoxyamphetamine) is a lesser-known psychedelic drug. It is the triethoxy analog of TMA-2. EEE was first synthesized by Alexander Shulgin. In his book PiHKAL, both the dosage and duration are unknown.[1] EEE produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of EEE.

See also

References

  1. ^ EEE Entry in PiHKAL


Categories